| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |